This is a preview of subscription content, log in via an institution to check access.
References
Veronesi, U., Adamus, J., Bandiera, D.C., Brennhovd, I.O., Caceres, E., Cascinelli, N., Claudio, F., Ikonopisov, R., Javorski, V.V., Kirov, S., Kulakowski, A., Lacour, J., Lejeune, F., Mechl, Z., Morabito, A., Rode, I., Sergeev, S., van Slooten, E., Szczygiel, K., Trapeznikov, N.N., Wagner, R.I.: Inefficacy of immediate node dissection in stage I melanoma of the limbs. N. Engl. J. Med.297:627, 1977
Sims, F.H., Taylor, W.F., Ivins, J.C., Pritchard, D.J., Soule, E.H.: A prospective management of malignant melanoma: preliminary results. Cancer41:948, 1978
Holmes, C., Mosley, H.S., Morton, D.L., Clark, W., Robinson, D., Marshall, M.U.: A rational approach to the surgical management of melanoma. Ann. Surg.186:481, 1977
Hellriegel, W.: Radiation therapy of primary and metastatic melanoma. Ann. N.Y. Acad. Sci.126:131, 1976
Habermalz, H.J., Fischer, J.J.: Radiation therapy of malignant melanoma. Experience with high individual treatment doses. Cancer38:2258, 1976
McBride, C.M., Sugarbaker, E.V., Hickey, R.C.: Prophylactic isolation perfusion as the primary treatment for invasive malignant melanoma of the limbs. Ann. Surg.182:316, 1975
Wanebow, H.J., Woodruff, J., Fortner, J.G.: Malignant melanoma of the extremities: a clinicopathologic study using levels of invasion (microstage). Cancer35:666, 1976
Wood, W.C., Cosimi, A.B., Carey, R.W., Kaufman, S.D.: Randomized trial of adjuvant therapy for “high-risk” primary malignant melanoma. Surgery83:677, 1978
Beretta, G., Bonadonna, G., Cascinelli, N., Morabito, A., Veronesi, U.: Comparative evaluation of three combination regimens for advanced malignant melanoma: results of an international cooperative study. Cancer Treat. Rep.60:33, 1976
Eilber, F.R., Morton, D.L., Holmes, E.C., Sparks, F.C., Ramming, K.P.: Adjuvant immunotherapy with BCG in treatment of regional lymph node metastases from malignant melanoma. N. Engl. J. Med.294:237, 1976
Hill, G.J., Grage, T.B., Menton, J.P., Johnson, R.O.: DTIC melanoma adjuvant study: final report. Sixtyninth Annual Meeting of the American Association for Cancer Research, ASCO abstract, 309, 1978
Cunningham, T.J., Schoenfeld, E., Nathanson, L., Wolter, J., Patterson, W.B., Cohen, M.H.: A controlled study of adjuvant therapy in patients with stage I and II malignant melanoma. In Immunotherapy of Cancer: Present Status of Trials in Man, Terry, W.D., Windhorst, D., editors. New York, Raven Press, 1978, p. 19
Banzet, P., Jacquillat, C., Civatte, J., Puissant, A., Maral, J., Chastang, C., Israel, L., Belaich, S., Jourdain, J.C., Weil, M., Auclerec, G.: Adjuvant chemotherapy in the management of primary malignant melanoma. Cancer41:1240, 1978
Costanza, M.E., Nathanson, L., Schoenfeld, D., Wolter, J., Colsky, J., Regelson, W., Cunningham, T., Sedransk, N.: Results with methyl-CCNU and DTIC in metastatic melanoma. Cancer40:1010, 1977
McKelvey, E.M., Luce, J.K., Vaitkevicius, V.K., Talley, R.W., Bodey, G.P., Lane, M., Moon, T.E.: BIS chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma. Cancer39:5, 1977
Holmes, E.C., Morton, D.L., Eilber, F.R., Golub, S.E., Sulit, H.L.: Immunotherapy in malignant melanoma. Natl. Cancer Inst. Monogr.44:85, 1976
Nathanson, L.: Regression of intradermal malignant melanoma after intralesional injection of mycobacterium bovis strain BCG. Cancer Chemother. Rep.56:659, 1972
Everall, J.D., O'Doherty, C.J., Dowd, P.M.: Treatment of primary melanoma by intralesional vaccinia before excision. Lancet2:583, 1975
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nathanson, L. Invited commentary. World J. Surg. 3, 341–343 (1979). https://doi.org/10.1007/BF01556588
Issue Date:
DOI: https://doi.org/10.1007/BF01556588